NRC Health Treasury Stock, Common, Value
NRC Health (NRC) had Treasury Stock, Common, Value of $82.39 million as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Balance Sheet › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:TreasuryStockCommonValue · last filed 2023-11-09
- 2023-09-30: Treasury Stock, Common, Value $82.39M.
- 2023-06-30: Treasury Stock, Common, Value $82.08M.
- 2023-03-31: Treasury Stock, Common, Value $80.25M.
- 2022-12-31: Treasury Stock, Common, Value $78.27M.
| Period end | Treasury Stock, Common, Value |
|---|---|
| 2023-09-30 | $82.39M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $82.08M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $80.25M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $78.27M 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |